Next Gen Digital Diagnostic Platform to Detect Multiple Pathogens within 5 Minutes at Gene Level
|
By HospiMedica International staff writers Posted on 30 Jun 2023 |
|
An advanced digital diagnostic platform with the capability to detect multiple pathogens in five minutes at the molecular gene level and priced significantly lower than current molecular tests is all set to disrupt the PCR market.
Check4 by IdentifySensors Biologics (Cleveland, OH, USA) is a next-generation digital diagnostic platform that has been developed to detect the genetic material of a wide range of pathogens for over-the-counter and point-of-care use. The Check4 testing platform comprises two components: a reusable Bluetooth reader roughly the size of a mobile phone, and disposable test cartridges that connect to the reader. Each test sample can simultaneously detect up to three different pathogens. Digital graphene sensors within the cartridges target conserved regions of the genome, thereby ensuring high sensitivity and specificity without the need for enzymatic amplification or reagents.
The sensors in the disposable cartridges can be customized to identify a broad range of pathogens that display similar symptoms. Multiplex tests are in development for respiratory pathogens (COVID, RSV, and influenza), gastrointestinal pathogens (Norovirus, Rotavirus, and Adenovirus), and sexually transmitted pathogens (HIV, Hepatitis, Chlamydia, Gonorrhea, and Herpes). Other tests under development include those for SEPSIS, MRSA, Lyme disease, and tropical pathogens such as Zika, Dengue, Yellow Fever, and West Nile virus. Previous research indicates that Check4 can potentially diagnose infections like COVID, RSV, and influenza even before patients exhibit symptoms. IdentifySensors has commenced testing this novel diagnostic device in anticipation of FDA submissions. Clinical studies for the Check4 diagnostic device are slated for this year as part of an extensive testing platform designed to be adapted for detecting a broad range of additional pathogens in the coming years.
"In preliminary studies we have seen encouraging results of this new technology," said Greg Hummer M.D., IdentifySensors co-founder and CEO. "We are excited to test these devices and move forward with additional targets that detect a wide range of infections."
Related Links:
IdentifySensors Biologics
Latest Point of Care News
- Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
- Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
- New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
- Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
- AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
- Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
- Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
- Portable MRI System Accelerates Emergency Brain Imaging and Triage
- Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
- Portable MRI System Gains CE Mark for Point-of-Care Brain Imaging
- AI-Enabled Platform Supports Clinical Decision-Making in Melanoma Detection
Channels
Artificial Intelligence
view channel
AI Tool Predicts Post-Heart Attack Trajectories to Personalize Follow-Up
Acute myocardial infarction (heart attack) survivors often develop new comorbidities and complications that unfold over years. Predicting which patients will deteriorate and where problems will arise remains... Read more
AI Digital Twin Platform Supports Personalized Cancer Treatment
Oncology teams face persistent challenges in tailoring treatment plans as tumors evolve and responses vary across patients. Static snapshots from imaging or genomics offer limited guidance for complex... Read more
Study Reveals Persistent Race and Gender Bias in Medical AI Models
Hospitals are turning to artificial intelligence (AI) to draft clinical materials and support decision-making, yet algorithmic bias can entrench inequities in care. When generated content reflects racial... Read more
New Study Highlights Benefits and Risks of AI Explanations in Clinical Diagnosis
Explainable artificial intelligence is increasingly used in tools that help clinicians and patients assess skin disease, but its explanations can influence decisions and contribute to overreliance or error.... Read moreCritical Care
view channel
Ultrasound Technique Enables Arrhythmia Risk Assessment in Mitral Valve Disease
Sudden cardiac death can occur when dangerous arrhythmias go undetected. Mitral valve prolapse and mitral regurgitation affect an estimated 2–5% of the population and have been linked to such events as... Read more
3D-Printed Membrane Could Enable Smaller, More Efficient Artificial Lungs
For patients with advanced lung disease, durable respiratory support is limited and donor organs are scarce. Extracorporeal membrane oxygenation (ECMO) can bridge failure, but current oxygenator membranes... Read more
Surgical Techniques
view channel
New Implant-Based System Gains FDA Approval for GERD Treatment
Gastroesophageal reflux disease is often treated surgically with techniques that encircle the esophagus, a strategy associated with dysphagia, inability to belch or vomit, and gas bloating.... Read more
Heartbeat-Powered Pacemaker Could Eliminate Battery Replacement Surgery
Pacemaker replacement surgeries expose patients to repeated procedural risks and added costs, particularly with leadless intracardiac systems that are difficult to explant once batteries deplete.... Read more
3D Bioprinting Method Enhances Bone Repair by Promoting Blood Vessel Growth
Severe bone loss after trauma, cancer, or infection is difficult to reconstruct because engineered grafts often fail to form stable blood vessels. Poor vascularization limits nutrient delivery, slows healing,... Read more
New Robotic Bronchoscopy Software Enhances Lung Nodule Navigation and Targeting
Accurate bronchoscopy to lung nodules can be technically challenging because patient anatomy may shift between pre-procedure computed tomography and the live procedure. These changes, together with CT-to-body... Read morePatient Care
view channel
Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
Emergency department (ED) boarding—the practice of keeping admitted patients in the ED while awaiting an inpatient bed—creates hazardous delays in definitive care. Prolonged transitions expose older and... Read more
Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
Fluoroscopy-guided procedures expose clinicians to scatter radiation that accumulates over time, creating persistent occupational risks in cath labs and interventional suites. Traditional badges typically... Read more
Medical Imaging
view channel
AI-Derived Brain Age from MRI Predicts Future Dementia Risk
Early identification of patients likely to progress to dementia remains difficult in memory clinics, where visual ratings of brain atrophy may miss subtle early changes. Dementia develops gradually and... Read more
Imaging Biomarkers Aim to Personalize Treatment for Post-Stroke Bladder Dysfunction
Post-stroke lower urinary tract dysfunction, including urinary incontinence, affects many stroke survivors and can persist long after the acute event. These symptoms undermine independence, burden caregivers,... Read more
Health IT
view channel
Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
Calcinosis cutis involves calcium deposits in the skin or soft tissues that can develop anywhere in the body, causing pain, impaired mobility, and disability. Lesions along the spine or buttocks can make... Read more
Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
Metastatic breast cancer, in which tumors spread to other organs, is incurable but increasingly managed with modern systemic therapies. As more treatments shift from hospital infusions to oral or at-home... Read more
Business
view channel
Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
Teledyne Technologies and Varex Imaging Corporation announced a definitive agreement on August 10, 2026, under which Teledyne will acquire all outstanding common shares of Varex for USD 18.... Read more
